Literature DB >> 5125763

Pharmacokinetics of phosphonomycin in Man. I. Intravenous administration.

K C Kwan, D A Wadke, E L Foltz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5125763     DOI： 10.1002/jps.2600600504

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  14 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis.

Authors:  Selma Tobudic; Peter Matzneller; Brigitte Stoiser; Judith Maria Wenisch; Markus Zeitlinger; Andreas Vychytil; Walter Jaeger; Michaela Boehmdorfer; Gottfried Reznicek; Heinz Burgmann
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

Review 3.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

4.  Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.

Authors:  P F Sonneville; R R Kartodirdjo; H Skeggs; A E Till; C M Martin
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

5.  Enhancement of drug absorption after administration by an automatic injector.

Authors:  F R Sidell; J E Markis; W Groff; A Kaminskis
Journal:  J Pharmacokinet Biopharm       Date:  1974-06

6.  An integrated approach to the pharmacokinetic analysis of drug absorption.

Authors:  A E Till; L Z Benet; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1974-12

7.  Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.

Authors:  W Brumfitt; J Kosmidis; J M Hamilton-Miller; J N Gilchrist
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

8.  The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.

Authors:  C Fernandez Lastra; E L Mariño; A Dominguez-Gil; J M Tabernero; A Gonzalez Lopez; M Yuste Chaves
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Fosfomycin trometamol: historical background and clinical development.

Authors:  G Gialdroni Grassi
Journal:  Infection       Date:  1990       Impact factor: 3.553

10.  Disposition of phosphomycin in patients with pleural effusion.

Authors:  C F Lastra; E L Mariño; M Barrueco; M S Gervós; A D Gil
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.